Cecilia Åkesdotter1, Göran Kenttä2, Sandra Eloranta3, Johan Franck4. 1. The Swedish School of Sport and Health Sciences, Department of Performance and Training, Sweden. Electronic address: cecilia.akesdotter@gih.se. 2. The Swedish School of Sport and Health Sciences, Department of Performance and Training, Sweden; School of Human Kinetics, University of Ottawa. 3. Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet. 4. Department of Clinical Neuroscience, Karolinska Institutet.
Abstract
OBJECTIVES: The first aim was to examine mental health problems (MHP) in elite athletes addressing prevalence, sex-differences, onset, recurrent episodes, help-seeking, symptoms of specific disorders and previous psychiatric diagnoses. The second aim was to investigate if sport-specific instruments could indicate clinical levels of psychiatric symptoms. DESIGN: Cross-sectional survey. METHODS: Elite athletes representing different Swedish national teams and applying for a university scholarship (n=333) answered a web-based survey. Females represented 58.9%. Mean age was 24.6(±3.1) years and 77.2% were individual- and 22.8% team-sport athletes. RESULTS: Lifetime prevalence of MHP was 51.7% (females 58.2%, males 42.3%). Point prevalence was 11.7% (females 13.8%, males 8.8%). Onset of first MHP episode peaked at age 19 with 50% of onsets between ages 17-21. Recurrent episodes were common, and females sought help more than males (females 37.8%, males 16.8%). Overall 19.5% reached the clinical cut-offs for symptoms of anxiety and/or depression (females 26.0%, males 10.2%). Previous psychiatric diagnoses existed among 8.1% (females 10.7%, males 4.4%). A depressive disorder, an eating disorder or a trauma and stress related disorder (self-reported as burnout) were most common. Finally, most sport-specific instruments (80%) demonstrated a fair diagnostic accuracy compared to clinically validated instruments. CONCLUSIONS: Lifetime prevalence of MHP was reported by more than half of the athletes. Symptoms manifested in young age and recurrent episodes were common. Sport-specific instruments indicating when symptoms reach clinical levels are potentially useful for data summary purposes on a group level, but without sufficiently high sensitivity and specificity to be recommend for applied work with athletes.
OBJECTIVES: The first aim was to examine mental health problems (MHP) in elite athletes addressing prevalence, sex-differences, onset, recurrent episodes, help-seeking, symptoms of specific disorders and previous psychiatric diagnoses. The second aim was to investigate if sport-specific instruments could indicate clinical levels of psychiatric symptoms. DESIGN: Cross-sectional survey. METHODS: Elite athletes representing different Swedish national teams and applying for a university scholarship (n=333) answered a web-based survey. Females represented 58.9%. Mean age was 24.6(±3.1) years and 77.2% were individual- and 22.8% team-sport athletes. RESULTS: Lifetime prevalence of MHP was 51.7% (females 58.2%, males 42.3%). Point prevalence was 11.7% (females 13.8%, males 8.8%). Onset of first MHP episode peaked at age 19 with 50% of onsets between ages 17-21. Recurrent episodes were common, and females sought help more than males (females 37.8%, males 16.8%). Overall 19.5% reached the clinical cut-offs for symptoms of anxiety and/or depression (females 26.0%, males 10.2%). Previous psychiatric diagnoses existed among 8.1% (females 10.7%, males 4.4%). A depressive disorder, an eating disorder or a trauma and stress related disorder (self-reported as burnout) were most common. Finally, most sport-specific instruments (80%) demonstrated a fair diagnostic accuracy compared to clinically validated instruments. CONCLUSIONS: Lifetime prevalence of MHP was reported by more than half of the athletes. Symptoms manifested in young age and recurrent episodes were common. Sport-specific instruments indicating when symptoms reach clinical levels are potentially useful for data summary purposes on a group level, but without sufficiently high sensitivity and specificity to be recommend for applied work with athletes.
Authors: Nanci S Guest; Trisha A VanDusseldorp; Michael T Nelson; Jozo Grgic; Brad J Schoenfeld; Nathaniel D M Jenkins; Shawn M Arent; Jose Antonio; Jeffrey R Stout; Eric T Trexler; Abbie E Smith-Ryan; Erica R Goldstein; Douglas S Kalman; Bill I Campbell Journal: J Int Soc Sports Nutr Date: 2021-01-02 Impact factor: 5.150
Authors: Tatjana Tubić; Bogdan Živanović; Nemanja Lakićević; Nataša Zenić; Barbara Gilić; Eduardas Rudas; Sergey Eliseev; Tatjana B Trivić; Antonino Bianco; Patrik Drid Journal: Front Psychol Date: 2022-04-29
Authors: Vita Pilkington; Simon M Rice; Courtney C Walton; Kate Gwyther; Lisa Olive; Matt Butterworth; Matti Clements; Gemma Cross; Rosemary Purcell Journal: Sports Med Open Date: 2022-07-06
Authors: Courtney C Walton; Simon Rice; Caroline X Gao; Matt Butterworth; Matti Clements; Rosemary Purcell Journal: BMJ Open Sport Exerc Med Date: 2021-03-05
Authors: Lewis King; Sarah Jane Cullen; Adrian McGoldrick; Jennifer Pugh; Giles Warrington; Gary Woods; Ciara Losty Journal: BMJ Open Sport Exerc Med Date: 2021-04-19
Authors: Toshio Kawai; Yuka Suzuki; Chihiro Hatanaka; Hisae Konakawa; Yasuhiro Tanaka; Aya Uchida Journal: Int J Environ Res Public Health Date: 2020-12-06 Impact factor: 3.390